Angiotensin II CLIA Kit
-
- Target Alle Angiotensin II (Ang II) CLIA Kits anzeigen
- Angiotensin II (Ang II)
-
Reaktivität
- Maus
- Nachweismethode
- Chemiluminescent
- Methodentyp
- Competition ELISA
- Detektionsbereich
- 24.69 pg/mL - 2000 pg/mL
- Untere Nachweisgrenze
- 24.69 pg/mL
- Applikation
- ELISA
- Verwendungszweck
- Mouse Angiotensin II CLIA Kit is a Competitive CLIA Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
- Proben
- Cell Culture Supernatant, Cell Lysate, Plasma, Serum, Tissue Homogenate
- Analytische Methode
- Quantitative
- Sensitivität
- < 9.34 pg/mL
- Featured
- Zu unserem meistverkauften Ang II ELISA Kit
- Top Product
- Discover our top product Ang II ELISA Kit
-
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle Angiotensin II (Ang II) CLIA Kits anzeigen
- Angiotensin II (Ang II)
- Andere Bezeichnung
- Angiotensin II (Ang II Produkte)
- Synonyme
- ANHU CLIA Kit, SERPINA8 CLIA Kit, ANRT CLIA Kit, Ang CLIA Kit, AngII CLIA Kit, PAT CLIA Kit, AI265500 CLIA Kit, AngI CLIA Kit, Aogen CLIA Kit, Serpina8 CLIA Kit, angiotensinogen CLIA Kit, angiotensinogen (serpin peptidase inhibitor, clade A, member 8) CLIA Kit, AGT CLIA Kit, Agt CLIA Kit
- Pathways
- JAK-STAT Signalweg, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Regulation of long-term Neuronal Synaptic Plasticity
-